Andecaliximab
id:
andecaliximab-191-10425907
title:
Andecaliximab
text:
Andecaliximab is an experimental humanized monoclonal antibody designed for the treatment of cancer and inflammatory diseases. This drug was developed by Gilead Sciences, Inc. Phase II and phase III trials for gastric cancer or gastroesophageal junction adenocarcinoma completed in 2019.
brand slug:
wiki
category slug:
encyclopedia
description:
Monoclonal antibody
original url:
https://en.wikipedia.org/wiki/Andecaliximab
date created:
date modified:
2023-11-17T02:57:37Z
main entity:
{"identifier":"Q48975957","url":"https://www.wikidata.org/entity/Q48975957"}
image:
fields total:
13
integrity:
14